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Oral squamous cells carcinoma (OSCC) shows unfavora-
ble prognosis due to its invasion potential around the neigh-
boring tissues and the elevated incidence of metastasis. Aim: 
the present paper aims at analyzing the immunohistochemical 
expression of the nm23 protein in metastatic and non-metas-
tatic SCCs of tongue. Methods: the immuno-expression to 
the nm23-hl protein was diagnosed in 35 tongue SCC (15 of 
which exhibiting metastasis). Nm23-hl immuno-scores were 
assigned as follow: score 0 = absent, 1 = focal and 2 = diffuse 
expression. Results: The Fisher’s exact test was performed 
and there was no statistical difference between the nm23-hl 
immuno-scores and the tongue SCCs studied cases (p=0.365), 
although 66.7% of metastatic cases presented negative nm23-
hl expression. Conclusions: Protein nm23 was not associated 
with a positiveness for tongue SCC without metastasis. Thus, 
several others factors inherent to host and malignancy can be 
associated with the mechanisms that suppress the metastatic 
process in this disease.
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INTRODUCTION
Head and neck carcinomas are the sixth most com-
mon cancer worldwide (INCA, 2006),1 the oral squamous 
cell carcinoma (OSCC) is the most frequent malignancy 
in this region. The prognosis of this entity in the mouth is 
poor; the local invasion and cervical lymph node metas-
tasis rates are high.2,3
Even with advances in oncological therapy, the 
five-year survival rate for patients with invasive OSCCs 
remains low (about 35%). Such morbidity rates may be 
due to factors such as varied responses to chemotherapy 
and radiotherapy, late presentation and delayed diagno-
sis. Although this malignancy has uniform morphological 
features, its biological behavior is heterogeneous, and 
tumors similarly staged may respond differently to the 
same treatment.4 Some authors have associated this clinical 
behavior with clinical staging (TNM) and anatomical site; 
those located in the tongue and floor of the mouth are 
considered more aggressive.5 Neck lymph node metastases 
and the TNM are the main measures of tumor aggressi-
veness, and are important parameters for planning the 
approach to such cases.
The metastatic process is complex; cells become 
dislodged from the primary tumor, the basement mem-
brane and extracellular matrix degrade and are invaded, 
the tumor cells avoid the immune response in the blood 
circulation and eventually colonize distant sites.6 This 
process is how cancer progresses, and is frequent in 
OSCCs, especially those in the tongue and floor of the 
mouth, which explains the poor survival rate of patients 
with this disease.7
Although various metastasis-related events and pro-
teins are known, certain aspects are poorly understood, 
such as why come tumors metastasize more frequently 
than others, as well as the identity of genes involved in 
this process. Identifying these genes may lead to the deve-
lopment of new strategies for the diagnosis and treatment 
of human cancers.
The nm23 gene appears to be involved in sup-
pressing the metastatic process. It was first described by 
Steeg et al. in 1988, in experiments where this gene was 
transfected to mice melanomas. This gene is a family con-
sisting of two genes in mice (nm23-1 and nm23-2) and six 
genes in humans, which code their respective proteins.6,8 
Decreased expression of its protein (nm23) in certain 
studies has been correlated with an increased metastasis 
rate and a poor prognosis in patients with breast, ovary, 
liver, stomach carcinomas and melanomas. This ratio, 
however, has not been demonstrated in neuroblastomas 
and bladder carcinomas.9 These findings remain unclear 
in OSCCs, as the few studies in this area have shown 
conflicting results.
More recently, a number of studies have investiga-
ted the relation between these genes and their expressed 
proteins with tumors in various anatomical sites; among 
these studies are those of Bertheau et al.,10 Fishman et 
al.,11 Kodera et al.,12 and Tokunaga et al.13 These studies 
have shown that nm23 protein expression is related with 
metastasis suppression in breast, thyroid, stomach and 
prostate carcinomas. Gunduz et al.11 found that the same 
applies to laryngeal squamous cell carcinomas; these au-
thors suggested that the expression of this protein could 
be used as an indicator of the prognosis.
Improved therapy for OSCC aiming at reducing its 
metastatic potential and aggressiveness is necessary to 
increase the survival rate of patients with this disease. The 
purpose of this paper was to assess the immunohistoche-
mical expression of the nm23-h1 protein in metastatic and 
non-metastatic squamous cell carcinomas of the tongue.
MATERIAL AND METHOD
This retrospective study (a historical cohort) invol-
ved selecting 35 cases of squamous cell carcinomas of the 
tongue. Paraffin-included surgical specimens of patients 
from which the tumor had been resected and which had 
or had not done postoperative chemotherapy and/or ra-
diotherapy were obtained. Sections 5 μm thick were made 
from these sections, which were then hematoxyllin-eosin 
stained for morphological analysis.
Cases with at least a 5-year follow-up were selected 
to investigate the presence of cervical lymph node metasta-
ses. Evidence for metastases in these cases was confirmed 
by image studies, such as computed tomography or mag-
netic resonance imaging, and/or morphological evidence 
in cervical dissection.
Sections 3 μm thick were made from the paraffin-
included specimens, which were then streptavidin-biotin 
stained for immunohistochemistry; the sequence was as 
follows: deparaffinization; hydration in decreasing ethanol 
sequences; removal of the formolic pigment with 10% 
ammonium hydroxide in 95º ethanol; blocking of endo-
genous peroxidase by a 10 volume hydrogen peroxide 
solution (two 10’ steps), followed by antigen recovery in 
a 25’ steamer with the TRIS-EDTA solution (pH 9.0) and 
incubation of the anti-nm23-h1 monoclonal antibody, 
at 1:100 dilution, for a 60’ incubation time. The material 
was immersed in a TRIS pH 7.4 buffer solution between 
reaction steps. Next, it was incubated with a secondary 
antibody and the streptavidin-biotin complex during 30 
minutes at room temperature; the reaction was developed 
with diaminobenzidine, followed by staining with Mayer’s 
hematoxyllin and mounting on a Permount slide.
Breast ductal carcinoma sections were used as po-
sitive controls for verifying the effectiveness of the tech-
nique; incubation with the primary antibody was omitted 
in the negative control.
Two examiners in a double-blind study did the 
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analysis of immune positivity; cases with brownish cyto-
plasmatic or nuclear staining were considered positive.
The Research Ethics Committee accepted this study 
(document number 72/03).
RESULTS
The 35 cases of squamous cell carcinomas of the 
tongue consisted of 19 male cases (54.28%) and 16 female 
cases (45.71%); the mean age was 65 years. There were 
22 patients that smoked cigarettes. Cervical lymph node 
metastases were found in 15 cases.
The tumor morphology was described as squamous 
cells with cellular and nuclear pleomorphism, nuclear 
hyperchromatism, prominent nucleoli, loss of the nuclear/
cytoplasmatic ratio, typical and atypical mitoses, nests of 
varied sizes permeating loose or dense stromal connective 
tissue, and an inflammatory infiltrate with blood vessels.
Immunohistochemically positive cells were those 
with a brownish color in the cytoplasm or nucleus (Figure 
1) based on the aforementioned analysis.
Table 1 shows the results of the immunohistochemi-
cal analysis of the nm23 protein in our sample of squamous 
cell carcinomas of the tongue.
Fischer’s exact test revealed no statistically signi-
ficant difference (p=0.365) in the comparison of immu-
nohistochemical nm23 protein marking in metastatic and 
non-metastatic squamous cell carcinomas of the tongue. 
Table 1 also shows that there was no positivity in 10 of 
15 metastasized cases.
DISCUSSION
According to De La Rosa et al.,15 the expression 
of nm23 gene coded proteins may be verified by using 
anti-nm23 antibodies, as was done in this study. We used 
the anti-nm23-h1 antibody in 35 cases of squamous cell 
carcinomas of the tongue to check whether protein expres-
sion occurred in cases of squamous cell carcinomas of the 
tongue with no metastases to regional lymph nodes. Those 
authors found that mRNA levels for both the nm23-h1 and 
the nm23-h2 were decreased in the MDA-MB435 metastatic 
cell line, compared to the non-metastatic line.
The option to specifically verify the immune expres-
sion of the nm23-h1 protein was based on Garzia et al.’s16 
statement that the nm23-h1 gene was the first gene to be 
discovered as having an important role in suppressing 
metastases. This expression induces anchorage-dependent 
cell colonization, making it difficult for ells to migrate.
The molecular mechanism of non-metastatic modu-
lation and well-differentiated nm23 phenotypes is poorly 
understood. Lombardi et al.17 and Postel et al.18 have 
stated that the nm23 gene and its proteins are expressed 
physiologically during cell growth and differentiation, and 
that this expression varies in tissues. It may be found in 
the nucleus and the cytoplasm, associated with microtu-
bules, on the cell and/or mitochondrial surface. Immune 
marking in our study was evident both in the nucleus and 
the cytoplasm of neoplastic cells. Khan et al.7 suggested 
a further mechanism in which cell migration may be inhi-
bited in OSCCs, even though metalloproteinase 2 and 9 
levels remain unaltered.
Ohtsuki et al.19 undertook an immunohistochemical 
analysis of nm23 protein expression in paraffin-included 
specimens of 33 OSCC cases and found that there may 
be suppression of metastases in this condition. Song et 
al.20 also reached this conclusion in a study of head and 
neck squamous cell carcinomas. These authors found 
no correlation with protein expression and the survival 
rate of patients. Wang et al.21 studied 86 OSCC cases and 
showed that smoking alters the expression of nm23-h1, 
facilitating disease progression. This may also have oc-
curred in our sample, as most of our cases were chronic 
cigarette smokers.
There are few published papers in the literature 
demonstrating the role of the nm23 protein in suppressing 
Figure 1. Immunohistochemical expression of the nm23-h1 protein 
in the cytoplasm of cells in the neoplastic squamous cell carcinoma 
of the tongue.
Table 1. Comparison of the immunohistochemical analysis of the 
nm23 protein in metastatic and non-metastatic squamous cell carci-







Absence 10 11 21
(Group  1) 66.7% 55%  
Diffuse marking 5 9 14
(Group 2) 33.3% 45%  
Total  15 20 35
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metastases in the mouth. We were motivated to undertake 
the current study because we found no paper in the world 
literature that used the nm23 protein only in squamous cell 
carcinomas of the tongue; most of the published studies 
had investigated adenocarcinomas.
Fischer’s exact test revealed no statistical signifi-
cance in the expression of the nm23-h1 protein between 
the metastatic and non-metastatic cases of squamous cell 
carcinomas of the tongue in our sample. As Table 1 shows, 
diffuse marking of the nm23-hq protein was more evident 
in cases with no metastases. A further point is that of 15 
metastatic cases, 10 were not immune-positive. Our results 
are similar to those of Göhring et al.22 in their 2002 paper, 
where nm23-h1 protein positivity was unrelated to me-
tastatic breast carcinomas. On the other hand, our results 
disagree with those of Nascimento et al.,23 who investigated 
benign and malignant salivary gland neoplasms and found 
that the presence of the nm23 protein in the nucleus may 
be a good indicator for predicting the metastatic potential 
of salivary gland malignancies.
CONCLUSION
Although we found no statistical significance betwe-
en squamous cell carcinomas of the tongue and expression 
of the nm23 protein, we cannot discard its protective role 
against metastases. Thus, further prospective studies with 
more uniform clinically staged groups of OCSS cases are 
needed to demonstrate the aforesaid role in the metastatic 
process.
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